Literature DB >> 2055054

Lipolytic response to metabolic stress in critically ill patients.

S Klein1, E J Peters, R E Shangraw, R R Wolfe.   

Abstract

OBJECTIVE: To measure whole-body lipolysis and fatty acid re-esterification in critically ill patients.
DESIGN: The rates of appearance of glycerol and palmitic acid in blood plasma were measured by infusing stable isotope tracers [2H5]glycerol and [1-13C]palmitic acid, respectively. Energy expenditure was measured by indirect calorimetry.
SETTING: Medical ICU of The University of Texas Medical Branch Hospital, a university-based referral center. PATIENTS: Five uninjured critically ill patients. Four patients were hospitalized because of respiratory insufficiency and one because of myocardial infarction. Three patients died during their hospitalization.
INTERVENTIONS: Metabolic studies were performed in each patient after an overnight (12-hr) fast.
MEASUREMENTS AND MAIN RESULTS: Mean +/- SE glycerol and fatty acid rates of appearance were 4.5 +/- 1.0 and 11.5 +/- 0.8 mumol/kg.min, respectively. The ratio of fatty acid to glycerol rate of appearance was 2.9 +/- 0.5. Resting energy expenditure was 132 +/- 6% of predicted.
CONCLUSIONS: An accelerated rate of lipolysis is part of the metabolic response to severe stress, regardless of its etiology. Because the rate of fatty acid release far exceeded energy requirements, fatty acids that were not oxidized as fuel were re-esterified to triglyceride, presumably in the liver.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2055054     DOI: 10.1097/00003246-199106000-00008

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  4 in total

Review 1.  Clinical potential of insulin therapy in critically ill patients.

Authors:  Dieter Mesotten; Greet Van den Berghe
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Effect of intravenous GLutamine supplementation IN Trauma patients receiving enteral nutrition study protocol (GLINT Study): a prospective, blinded, randomised, placebo-controlled clinical trial.

Authors:  Ruqaiya M Al Balushi; Jennifer D Paratz; Jeremy Cohen; Merrilyn Banks; Joel Dulhunty; Jason A Roberts; Jeffrey Lipman
Journal:  BMJ Open       Date:  2011-11-14       Impact factor: 2.692

3.  Metabolic Profiling of Children Undergoing Surgery for Congenital Heart Disease.

Authors:  Goncalo D S Correia; Keng Wooi Ng; Anisha Wijeyesekera; Sandra Gala-Peralta; Rachel Williams; S MacCarthy-Morrogh; Beatriz Jiménez; David Inwald; Duncan Macrae; Gary Frost; Elaine Holmes; Nazima Pathan
Journal:  Crit Care Med       Date:  2015-07       Impact factor: 7.598

4.  Aqua walking as an alternative exercise modality during cardiac rehabilitation for coronary artery disease in older patients with lower extremity osteoarthritis.

Authors:  Jong-Young Lee; Kee-Chan Joo; Peter H Brubaker
Journal:  BMC Cardiovasc Disord       Date:  2017-09-21       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.